Vijay K Lathi
CIK 1340806 · last filed 2018-05-31
Vijay K Lathi is a corporate insider who has filed 17 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ITRM, was dated May 31, 2018. Across all open-market trades the lifetime net is −$216.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.4M across reported positions. 29 SEC filings were submitted jointly with Philippe O. Chambon.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.42M
6
17
-$216.69M
Filer Profile
2500 SAND HILL ROAD, SUITE 203
MENLO PARK, CA 94025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Iterum Therapeutics plc (ITRM) Delisted | 10%+ Owner | 25,641 | $0.03 | $769 | $17.23M | 1 | 2018-05-31 |
| IRTC | Director | 85,785 | $109.77 | $9.42M | -$80.59M | 10 | 2018-03-12 |
| Durata Therapeutics, Inc. (DRTX) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2014-11-18 |
| Aravive, Inc. (VSAR) Delisted | 10%+ Owner | 426,562 | — | — | -$126.23M | 2 | 2014-11-13 |
| Lite Strategy, Inc. (MEIP) Delisted | 10%+ Owner | 84,024 | $3.20 | $268.9K | -$27.10M | 1 | 2013-11-25 |
| SGX PHARMACEUTICALS, INC. (SGXP) Delisted | Director | — | — | — | $0 | 1 | 2007-05-17 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-31 | Iterum Therapeutics plc (ITRM) Delisted | Mixed | +2,912,606 | $17.23M | EDGAR |
| 2018-03-12 | IRTC | Sell (S) | −114,018 | -$7.58M | EDGAR |
| 2018-02-26 | IRTC | Sell (S) | −45,723 | -$3.00M | EDGAR |
| 2018-02-22 | IRTC | Sell (S) | −169,000 | -$10.55M | EDGAR |
| 2017-12-07 | IRTC | Sell (S) | −150,000 | -$7.88M | EDGAR |
| 2017-11-20 | IRTC | Sell (S) | −225,000 | -$11.72M | EDGAR |
| 2017-09-15 | IRTC | Mixed | +37,776 | -$1.71M | EDGAR |
| 2017-07-07 | IRTC | Grant (A) | +1,405 | $0 | EDGAR |
| 2017-06-08 | IRTC | Sell (S) | −430,624 | -$16.19M | EDGAR |
| 2017-05-16 | IRTC | Sell (S) | −645,000 | -$22.38M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.